Cardiovascular Disease Risk Factors in Chinese American Immigrants

Hypertension Clinical Trial

— CHA-CHA  

Official title:

Chinese American Cardiovascular Health Assessment CHA-CHA

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00362128
• Other study ID #: 2005-400
• Secondary ID: R01HL077809
• Status: Completed
• Start date: January 2007
• Est. completion date: October 2009

Study information

• Verified date: January 2020
• Source: Albert Einstein College of Medicine
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The Chinese population is currently the fastest growing ethnic group in New York City (NYC). Research has shown that Chinese immigrants living in NYC have higher rates of cardiovascular disease (CVD) than individuals in China. This study will evaluate the effect that acculturation has on health habits and CVD risk factors in Chinese immigrants living in NYC.

Description:

CVD includes diseases that affect the heart and blood vessels. The underlying cause of CVD is atherosclerosis, in which fatty plaques develop on the inner walls of arteries. There are many risk factors for CVD, including inflammation, high blood pressure, high cholesterol, and obesity. Research has shown that CVD mortality rates differ greatly between Chinese immigrants living in NYC and individuals living in China. Because of this difference, it is important to understand the impact of immigration and acculturation on health habits and psychosocial factors, which may influence the development of CVD. This study will gather information from Chinese immigrants in NYC to identify the impact of immigration and acculturation on behavior and CVD risk factors. In addition, results from this study may provide insight into the CVD risk patterns in other immigrant groups.

This study will enroll Chinese immigrants living in NYC. Participants will attend one study visit and will complete questionnaires to assess their health habits (diet, physical activity, and smoking), stress levels, and socioeconomic status. Participants will also undergo a physical examination and blood collection.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 2072
• Est. completion date: October 2009
• Est. primary completion date: July 2009
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Chinese immigrant

• Currently residing in NYC

Exclusion Criteria:

• Under 18 years of age

• Not of Chinese dissent

• Born outside mainland China

Related Conditions & MeSH terms

• Cardiovascular Diseases
• Diabetes Mellitus
• Hypertension
• Metabolic Syndrome
• Metabolic Syndrome X

Locations

Country	Name	City	State
United States	New York Downtown Hospital	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
Albert Einstein College of Medicine	National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of Participants With Hypertension	Systolic BP above 129 or Diastolic BP above 79.	4 years